Stocks
REGENXBIO (RGNX) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 3.51 | -2.31 | 1.05 | 1.03 | 0.74 | 0.67 | ||
| Changes by years, y/y, % | +143% | -166% | -146% | -2% | -28% | |||
REGENXBIO. Debt/EBITDA
REGENXBIO. Debt/EBITDA, changes, %
REGENXBIO (RGNX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 0.95 | 0.88 | 0.82 | 0.72 | 0.67 | 0.67 | ||
| Changes by years, y/y, % | -146% | -138% | -133% | -33% | -29% | |||
| Changes by quarters, q/q, % | -11% | -7% | -7% | -13% | -7% | |||
